ixabepilone

View Patient Information

An orally bioavailable semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	azaepothilone B epothilone epothilone B lactam epothilone-B BMS 247550
US brand name:	Ixempra
Code name:	BMS-247550
Chemical structure:	(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
NSC code:	710428

ixabepilone

Search NCI's Drug Dictionary